Skip to content

News archive

After seven years as the CEO of Umeå based Medicvent, Erik Lindström transitions to a new role as Business Unit Manager within Sdiptech.

Leadership change ahead as Medicvent's CEO transitions within Sdiptech

Medicvent, based in Umeå, is seeking a new CEO as Erik Lindström transitions to a role within parent company Sdiptech. Founded in 1983, Medicvent focuses on air pollutant evacuation solutions for healthcare and plans to continue to expand internationally.

Mucocort AB is developing an innovative mucoadhesive "patch" for mouth ulcers (aphthous stomatitis), one of the most common oral mucosal diseases. The Chinese patent secures Mucocort's technology in one of the largest markets globally.

Mucocort receives additional patent approval for its innovative patch technology

The Swedish MedTech company Mucocort AB has been granted a patent in China for its innovative product/technology, which has previously been approved under the European Patent System (EPC). Mucocort develops a mucoadhesive "patch" for mouth ulcers (aphthous stomatitis), one of the most common oral mucosal diseases.

"Our plastic-free control release system allows nutrition to be released in a delayed and multi-phased manner that matches plant needs", says Jonathan Love, CEO and founder of Cropcision.

Plastic-free fertilizers from Swedish startup could boost sustainable sunflower production

In 2025, the Swedish Ag-Tech startup Cropcision will run a trial of its plastic-free precision fertilizers for sustainable sunflower production in Spain, supported by EIT Food. Cropcision aims to improve the financial and environmental performance of farms, forests, and greenhouses, aligning with the EU's Farm-to-Fork goal to reduce fertilizer use by 20 percent by 2030.

After a decade in the startup world, Sofia Mayans joins Diamyd Medical in Umeå as Director of Business Development. "It feels rewarding as Diamyd focuses on diabetes, the area I completed my PhD in” she says. Photo: Fredrik Larsson

Experienced life science leader joins Diamyd Medical in Umeå

Sofia Mayans, a seasoned life science professional and co-founder of InfiCure Bio, has joined Diamyd Medical in Umeå as Director of Business Development, focusing on leveraging new production capabilities and exploring additional business opportunities related to diabetes treatment.

Alice Kempe, Chairman of the Board at Kempestiftelserna, and Markus Thor, the CEO of QureTech Bio. Kempestiftelserna is a new shareholder in QureTech Bio, which is developing novel antibiotics and anti-infectives.

QureTech Bio secures major investment from Kempestiftelserna

QureTech Bio has secured a SEK 14 million investment from Kempestiftelserna and Nascent Invest to enhance its development of innovative antibiotics targeting antimicrobial resistance. The funding will accelerate programs addressing multidrug-resistant bacteria, significantly impacting global health advancements.

The new Chairman has a broad background in the innovation ecosystem. Besides his CEO post at SLU Holding he serves on several Swedish incubator boards. Photo: Göran Ekeberg/Add Light

Experienced CEO appointed Chairman of Umeå Biotech Incubator

Urban Eriksson has been appointed Chairman of Umeå Biotech Incubator, bringing 30 years of leadership experience, notably as CEO of SLU Holding. He emphasizes the importance of bridging research and practical applications in life sciences for sustainable development.

Martin Hanberger is the founder and designer behind the medical vest that conceals fluids, pumps and tubing within the garment. "Making things easier for the children during treatment has always been our driving force" he says.

Global push for medical vest that aims to enable cancer treatment for children

Umeå based Nil Medical has developed an ergonomic, medical vest for children undergoing cancer treatment, allowing for greater mobility by concealing IV equipment within the garment. The vest is being evaluated in a national quality of life study, in collaboration with Swedish healthcare. Nil Medical aims to introduce the CE-marked "Vestpack" to the international market.

Christian Hedberg is developing a new treatment of cryptosporidiosis and is working closely with Umeå Biotech Incubator to bring the treatment to the market. PHOTO: Mattias Pettersson/Umeå University

New UBI Case Aims to Revolutionize Treatment of Cryptosporidiosis

Christian Hedberg, a professor at Umeå University, is developing a revolutionary drug to treat cryptosporidiosis in animals and humans. He collaborates with France's INRAE and the treatment has shown promising results in ruminant models and has the potential to address a significant global health issue. Christian Hedberg has joined Umeå Biotech Incubator to bring the treatment to the market.

Lina Olsson, CEO of HiloProbe, which works in the cancer diagnostics field. The companys has developed ColoNode, a reagent kit for analyzing lymph nodes in colorectal cancer patients.

HiloProbe secures 3 SEK Million in funding for sales initiation

HiloProbe, based in Umeå, secures SEK 3 million in funding from existing owners for sales initiation. The capital injection aims to attract more investment and reach a break-even point. The company is close to a breakthrough with ColoNode, a reagent kit for analyzing lymph nodes in colorectal cancer patients.

Umeå is the cornerstone in the regional development projects "Life Science City" and "SOLH". Peter Jacobsson is Operations Coordinator at Umeå Biotech Incubator and Mats Falck is project leader for the SOLH project.

SEK 22 Million in EU funding elevates the Life Science sector in Umeå

Umeå secures 1.8 million (22 SEK million) in EU funding for life science projects to boost innovation and industry growth. The project "Life Science City" is run by Umeå Biotech Incubator and seeks to expand the sector and strengthen collaborations. The SOLH project is a joint effort between Västerbotten and Norrbotten aiming to streamline and unify the innovation system.

Show more

We grow ideas that can change the world

Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.

Umeå Biotech Incubator
Umeå Biotech Incubator

Tvistevägen 48C
907 36 Umeå
Sweden